This inventor holds 1 USPTO granted patent. Top assignee: Pacesetter, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Craig D. Markovitz: Innovator in Cardiac Resynchronization Therapy
Introduction
Craig D. Markovitz is a notable inventor based in Jefferson Hills, PA (US). He has made significant contributions to the field of cardiac resynchronization therapy (CRT). His innovative work focuses on optimizing methods for intraoperative guidance in CRT, which is crucial for improving patient outcomes.
Latest Patents
Markovitz holds a patent for "Systems for, and methods of, guidance based intraoperative cardiac resynchronization therapy optimization." This patent outlines a method of optimizing CRT by administering candidate pacing settings at a lead implantation site. The process involves determining a navigation sensor path for each candidate pacing setting and identifying the path that corresponds to the most efficient cardiac tissue displacement. This innovation has the potential to enhance the effectiveness of CRT procedures.
Career Highlights
Throughout his career, Craig D. Markovitz has been associated with Pacesetter, Inc., a company known for its advancements in cardiac devices. His work has contributed to the development of technologies that improve the quality of life for patients with heart conditions. With 1 patent to his name, he continues to be a valuable asset in the medical technology field.
Collaborations
Markovitz has collaborated with talented individuals such as Wenbo Hou and Chunlan Jiang. These partnerships have fostered an environment of innovation and have led to advancements in cardiac therapy technologies.
Conclusion
Craig D. Markovitz is a pioneering inventor whose work in cardiac resynchronization therapy optimization is making a significant impact in the medical field. His contributions are essential for advancing patient care and improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile